StemCell Therapy

Request Download SampleAsk For Discount Company Profile

New Jersey, United States,- Stem Cell Therapy Market Report gives a detailed analysis of the market. After a detailed examination of the current trends, the report shares the details around the factors fueling the markets momentum.

Forgiving an in-depth review of the market, the report showcases the factors that are affecting the markets overall growth. From network partners, production methods to revenue generating techniques, every detail is added in the report. In addition, the Stem Cell Therapy report has enclosed the data about the established players of the market.

Stem Cell Therapy report has a dedicated section that highlights the actions that can be appointed for global level expansion. The report is designed to guide through every step from planning till implementation.

The major players covered in the Stem Cell Therapy market are

Osiris Therapeutics Medipost Co. Ltd. Anterogen Co. Ltd. Pharmicell Co. Ltd. HolostemTerapieAvanzateSrl JCR Pharmaceuticals Co. Ltd. Nuvasive RTI Surgical Allosource

It is worth noting that the Stem Cell Therapy market report also gives a complete overview in terms of volume, market value, demand and supply. All these factors add up to become the market dynamics of the Stem Cell Therapy market. For leaping ahead of the competition and to make the most out of the emerging opportunities, it is essential to understand the market dynamics.

As per the Verified Market Reports experts, the Stem Cell Therapy market is going to balloon in terms of revenue and customer base. This conclusion was drawn out from the market indicators that are considered in the Stem Cell Therapy market report to form curated data. The crucial pieces of data are included in the form of tables, charts and graphs to give a visual representation of the complex and huge database.

What key insights does the Stem Cell Therapy market research provide?

Past and current revenue statistics of the Stem Cell Therapy market players analyzed at the regional level. Individual profiling of major stakeholders. Analysis of the Stem Cell Therapy market size on the basis of product type and end-use type. Accurate Stem Cell Therapy market forecast of volume in numbers and percentages. Demand prospect of individual segments covered in the Stem Cell Therapy report.

Segmentation of Stem Cell Therapy Market:

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Stem Cell Therapy Market Report Scope

What queries are resolved by the Stem Cell Therapy market research?

1. What are the restraints slowing down the progress of Stem Cell Therapy market?2. Why are the end consumers getting more inclined towards alternative Stem Cell Therapy market products?3. How the Stem Cell Therapy market expected to shape in the next septennial?4. What strategies are being appointed by the major players of the Stem Cell Therapy market to stay ahead of the competition?5. What innovative technologies are being used by the established players of the Stem Cell Therapy market to stay ahead of the competition?

Why choose Verified Market Reports?

Smart dashboard to provide details about updated industry trends. Data collection from different network partners such as suppliers, vendors, service providers, for giving out a clear perspective of the Stem Cell Therapy market. Strict quality checking standards Data collection, triangulation, and validation. 24/7 at your service.

Visualize Stem Cell Therapy Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment and Key players of your market. Present your Market Report & findings with inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us: Verified Market Reports

Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information enriched research studies.

We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyse data on more than 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Our research spans over a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768

Email: sales@verifiedmarketreports.com

Website: https://www.verifiedmarketreports.com/

Follow this link:
Stem Cell Therapy Market Size, Growth Opportunities, Trends, Key Players and Forecast to 2027 - The Courier

Fort Collins, Colorado: A new informative report on the Global Animal Stem Cell Therapy Market has recently been published by Reports Globe and added to its widespread database which will help to make better strategic decisions in the businesses. It makes use of different proven research methodologies such as primary and secondary research methodologies to collect data from different sources. It comes with an in-depth analysis of global market segments and sub-segments which helps to understand the current situation of the global Animal Stem Cell Therapy market. Additionally, it makes use of some significant graphical presentation techniques such as graphs, charts, diagrams, and pictures to get easy understanding to readers. Moreover, it offers summarized data on various business perspectives such as global market shares, drivers, restraints, recent innovative trends, and challenges in front of the global Animal Stem Cell Therapy market.

In addition, this research is categorized differently considering the various aspects of this global Animal Stem Cell Therapy market. It also evaluates the current situation and the future of the market by using the forecast horizon. The forecast is analyzed based on the volume and revenue of this market. The tools used for analyzing the global Animal Stem Cell Therapy Market research report include the porters five forces analysis and SWOT analysis.

Get Exclusive Sample of Report on Animal Stem Cell Therapy Market is Available @ https://reportsglobe.com/download-sample/?rid=102435

Some of the Important and Key Players of the Global Animal Stem Cell Therapy Market:

Geographically, the global Animal Stem Cell Therapy market has been scrutinized into different global regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, and Europe on the basis of different attributes like manufacturing base and productivity of the companies. The expert team of researchers throws light on leading key players to get accurate and informative data of global key players. It makes use of analysis techniques such as SWOT and Porters five-technique to analyze the data of the global Animal Stem Cell Therapy market. Additionally, different facts and figures are also included in the report to present data of global Animal Stem Cell Therapy market more effectively for better and easy understanding to readers

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=102435

The Global Animal Stem Cell Therapy market is segmented based by type, application, and region.

Animal Stem Cell Therapy Market Segmentation, By Type

Animal Stem Cell Therapy Market Segmentation, By Application

The best thing about this global Animal Stem Cell Therapy market research report is that the significance and application scope of this market has been defined. Besides, various market dynamics and buying criteria have been enhanced in the report. Hence, this market research report is a great scope for identifying new investments in the global Animal Stem Cell Therapy market and, identifying how to deal with the market trends, etc. of the global Animal Stem Cell Therapy market.

To conclude, the examination of the current market chain, existing norms and policies, and the initiatives taken by the government to promote the global Animal Stem Cell Therapy market all over the world. Apart from this, a detailed analysis of the manufactured products, their production chain, price structures of the Animal Stem Cell Therapy market has also been studied in this report.

Browse the complete report @ https://reportsglobe.com/product/global-animal-stem-cell-therapy-market-insight-and-forecast/

Following major questions have been addressed through global research report:

1. What will be the global market size and growth rate over the forecast period?2. What are the major trending technologies for increasing the performance of the global Animal Stem Cell Therapy market?3. What are the outcomes of industry analysis techniques such as SWOT and porters five techniques?4. What are the demanding regions for global Animal Stem Cell Therapy market?5. How to expand coverage of global Animal Stem Cell Therapy market?6. What are the effective ways to explore global growth opportunities?7. What are the driving factors for fueling the growth of the global Animal Stem Cell Therapy market?8. Which factors are hampering the global market growth?

Different dynamics of the global Animal Stem Cell Therapy market are also studied in the global research report such as drivers, restraints, opportunities and threats in front of the global market. Moreover, it includes some sales methodologies and some standard operating procedures to enhance the outcomes of the businesses.

Major Points from Table of Content:

1. Executive Summary2. Assumptions and Acronyms Used3. Research Methodology4. Animal Stem Cell Therapy Market Overview5. Animal Stem Cell Therapy Supply Chain Analysis6. Animal Stem Cell Therapy Pricing Analysis7. Global Animal Stem Cell Therapy Market Analysis and Forecast by Type8. Global Animal Stem Cell Therapy Market Analysis and Forecast by Application9. Global Animal Stem Cell Therapy Market Analysis and Forecast by Sales Channel10. Global Animal Stem Cell Therapy Market Analysis and Forecast by Region11. North America Animal Stem Cell Therapy Market Analysis and Forecast12. Latin America Animal Stem Cell Therapy Market Analysis and Forecast13. Europe Animal Stem Cell Therapy Market Analysis and Forecast14. Asia Pacific Animal Stem Cell Therapy Market Analysis and Forecast15. Middle East & Africa Animal Stem Cell Therapy Market Analysis and Forecast16. Competition Landscape

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://reportsglobe.com/need-customization/?rid=102435

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Originally posted here:
Animal Stem Cell Therapy Market Size, Business Growth Tactics, Future Strategies, Competitive Outlook and Forecast to 2027 Jumbo News - Jumbo News

The report by Zion Market Research titled How Will Global Stem Cell Therapy Market React from 2021 Onwards?Research Reportpresents a profound comprehension regarding the functioning and expansion of theStem Cell Therapy Marketon a regional and global level. This analysis report is the collation of all the wide-ranging information relating to the market statistics during the recent years as well as forecasts for coming years. To begin with, the report comprises the major players actively participating and competing within the Stem Cell Therapy Market; it entails several companies, manufacturers, suppliers, organizations, and so on. Thus, the report will assist in understanding the initiatives and approaches implemented by these players to create and reinforce their market presence. The thorough analysis presents a wide-ranging comprehension of the global market in a knowledgeable way. The client can merely point out the steps of the firm by having details regarding their global revenue, market share, price, production & capacity, and recent developments during the forecast period.

Request Free Sample Report of Stem Cell Therapy Market Report @ https://www.zionmarketresearch.com/sample/stem-cell-therapy-market

Key players leveraging the business growth are

Anterogen Co., Ltd., RTI SurgicalInc., Pharmicell Co., Ltd., MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Holostem Terapie Avanzate S.r.l., NuVasiveInc., and AlloSource.

The research report includes the outline of the global Stem Cell Therapy Market such as definition, classifications, and applications. Apart from this, it entails the comprehensive assessment of a number of factors like constraints, opportunities, drivers, challenges, and risk. Further, the global Stem Cell Therapy Market is bifurcated on the basis of diverse parameters into respective segments as well as sub-segments. The report also encompasses the existing, previous, and likely growth trends within the market for each segment and sub-segment[Product, Applications, End-Users, and Major Regions]. Additionally, the market is also segregated based on regions[North America, Europe, Asia-Pacific, Latin America, The Middle East & Africa].along with detailed evaluation of their growth, key developments & strategies, opportunities, and the key patterns influencing the market expansion in those regions. The report will further also entail a particular part putting forth the changes and of the ongoing COVID-19pandemic. It comprises-depth market analysis rooted in the predictions of post-COVID-19 market circumstances together with data on the existing impacts on the Stem Cell Therapy Marketof the pandemic.

Global Stem Cell Therapy Market: Regional Segment Analysis

The research report also highlights the wide array of tactical steps, such as the latest business deals, joint ventures, partnerships, M&As, technological developments, and the launch of new products taking place in the market. In addition, it scrutinizes several patterns of the global Stem Cell Therapy Market, entailing the rules, criteria, and policy deviations implemented by the private companies and government on the market over the last few years. As a final point, the analysis includes forecasts and historic data making it a beneficial asset for experts, industry executives, presentation, sales & product managers, consultants, and every other person or organization looking for essential market data and statistics.

Download Free PDF Report Brochure @https://www.zionmarketresearch.com/requestbrochure/stem-cell-therapy-market

Research objectives

Frequently Asked Questions

Browse Press Release @https://www.zionmarketresearch.com/news/stem-cell-therapy-market

Why Choose Zion Market Research?

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesTel: +49-322 210 92714USA/Canada Toll-Free No.1-855-465-4651Email:sales@zionmarketresearch.comWebsite:https://www.zionmarketresearch.com

Read this article:
How Will Global Stem Cell Therapy Market React from 2021 Onwards? - The Courier

Canine Stem Cell Therapy Market research report is the new statistical data source added by A2Z Market Research.

Canine Stem Cell Therapy Market is growing at a High CAGR during the forecast period 2021-2027. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Canine Stem Cell Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=382775

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

Aratana Therapeutics, Okyanos, Magellan Stem Cells, Stem Cell Vet, VetStem Biopharma, Medrego, Regeneus Ltd, MediVet Biologic, Cell Therapy Sciences.

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Canine Stem Cell Therapy market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Canine Stem Cell Therapy markets trajectory between forecast periods.

Global Canine Stem Cell Therapy Market Segmentation:

Market Segmentation: By Type

Allogeneic Stem CellsAutologous Stem Cells

Market Segmentation: By Application

Veterinary HospitalsVeterinary ClinicsVeterinary Research Institutes

Get up to 30% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=382775

Regions Covered in the Global Canine Stem Cell Therapy Market Report 2021: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The cost analysis of the Global Canine Stem Cell Therapy Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Canine Stem Cell Therapy market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Canine Stem Cell Therapy market.

Table of Contents

Global Canine Stem Cell Therapy Market Research Report 2021 2027

Chapter 1 Canine Stem Cell Therapy Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Canine Stem Cell Therapy Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=382775

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

https://neighborwebsj.com/

See original here:
Impact of COVID-19 on Canine Stem Cell Therapy Market by 2027 |Aratana Therapeutics, Okyanos, Magellan Stem Cells, Stem Cell Vet, VetStem Biopharma -...

Canine Stem Cell Therapy Market research report is the new statistical data source added by A2Z Market Research.

Canine Stem Cell Therapy Market is growing at a High CAGR during the forecast period 2021-2027. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Canine Stem Cell Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=21262

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, .

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Canine Stem Cell Therapy market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Canine Stem Cell Therapy markets trajectory between forecast periods.

Global Canine Stem Cell Therapy Market Segmentation:

Market Segmentation: By Type

* Allogeneic Stem Cells* Autologous Stem cells

Market Segmentation: By Application

* Veterinary Hospitals* Veterinary Clinics* Veterinary Research Institutes

Get up to 30% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=21262

Regions Covered in the Global Canine Stem Cell Therapy Market Report 2021: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The cost analysis of the Global Canine Stem Cell Therapy Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Canine Stem Cell Therapy market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Canine Stem Cell Therapy market.

Table of Contents

Global Canine Stem Cell Therapy Market Research Report 2021 2027

Chapter 1 Canine Stem Cell Therapy Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Canine Stem Cell Therapy Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=21262

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

https://neighborwebsj.com/

View post:
Impact of COVID-19 on Canine Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | VETSTEM BIOPHARMA, Cell...

The Global Animal Stem Cell Therapy Market Report is a comprehensive and professional survey that describes the landscape structure of Animal Stem Cell Therapy . This market research report gives you a detailed market overview, product definitions, specifications, and research objectives. Also, market size estimates, concentration, and maturity analysis are presented in the first section of the report.

The global Animal Stem Cell Therapy market value and growth rate from 2015 to 2025 is presented in this report. To provide a complete market view, the survey is fragmented based on type, Animal Stem Cell Therapy application, and research area. This study provides growth, competitive analysis, and development prospects across different regions.

Download free sample Report https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#request_sample

Medivet Biologics LLCVETSTEM BIOPHARMAJ-ARMU.S. Stem Cell, IncVetCell TherapeuticsCelavet Inc.Magellan Stem CellsKintaro Cells PowerAnimal Stem CareAnimal Cell TherapiesCell Therapy SciencesAnimacel

Global Market segments:

Market By Type:

DogsHorsesOthers

Market By Application:

Veterinary HospitalsResearch Organizations

Up to 40% Off On Selected Report, Ask For Discount :https://www.globalmarketers.biz/discount_inquiry/discount/130268

Major Regions that play a vital role in the Animal Stem Cell Therapy market are:

This report describes development policies and plans, growth prospects, manufacturing processes, and cost structure. This report shows Animal Stem Cell Therapy consumption statistics, import/export scenarios, revenue, and gross profit analysis. It also evaluates the supply and demand aspects of Animal Stem Cell Therapy , its presence in the global and regional market, costs, and prices of products. Animal Stem Cell Therapy simplified financial information is obtained from a variety of data sources to provide reliable, accurate, and concise information.

Browse full Description, TOC, : https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#table_of_contents

The Animal Stem Cell Therapy Key market trends, growth opportunities, regional analysis, strategic recommendations, and new Animal Stem Cell Therapy segments are thoroughly investigated. This report studies the market segments based on Animal Stem Cell Therapy types, applications, and regions. Animal Stem Cell Therapy well-established players, their revenue, market share, gross margins, and prices are detailed in this report. This study presents a SWOT analysis of major industry players, strategic assessments, capacity, and value presented in this comprehensive report.

Global Animal Stem Cell Therapy Market Overview 2019

Global Animal Stem Cell Therapy Market and Regional Animal Stem Cell Therapy Market analysis 2015-2025 Animal Stem Cell Therapy Market Size and Forecast Analysis by the main players of the industry Numerous Animal Stem Cell Therapy market segmentation surveys and regional production analysis Animal Stem Cell Therapy Detailed information on the manufacturing method and price structure. Market supply and demand analysis, production, current and future forecast data for Animal Stem Cell Therapy industry Top Animal Stem Cell Therapy downstream threats and market share prospects

This comprehensive document answers the following questions:

1. What is the size of the Animal Stem Cell Therapy market globally and regionally?2. Which are the top countries in Animal Stem Cell Therapy ? And how big is the market?3. Which regions have good market potential and investment feasibility?4. What are the growth opportunities for the Animal Stem Cell Therapy market over the next few years?5. Who are the best players and what is their market share?6. What are the risk factors that affect market growth?7. What are the supply/demand and gross margin statistic for each market player?

Get Free Sample report https://www.globalmarketers.biz/report/life-sciences/global-animal-stem-cell-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130268#request_sample

See the original post:
Global Animal Stem Cell Therapy Market Size| Share| Trends and Analysis | Industry Growth Insight By 2025 Globalmarketers.biz Jumbo News - Jumbo...

Adroit Market Research, the fastest growing market research company, has published a report on the Stem Cell Therapy market. This market report provides a holistic scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report covers the competitive data analysis of the emerging and prominent players of the market. Along with this, it provides comprehensive data analysis on the risk factors, challenges, and possible new market avenues.

The report has been prepared with the help of a robust research methodology to cover the market in a detailed manner. To publish a top-notch Stem Cell Therapy Market report, the market report has undergone extensive primary and secondary research. The dedicated research team conducted interviews with the delegated industry experts to lay out a complete overview of the market. This market research report covers the product pricing factors, revenue drivers, and growth. Furthermore, it can possibly assist the new entrants and even the existing industry players to tailor a strategic business strategy for their products.

Get PDF Sample Report of Stem Cell Therapy (COVID-19 Version) Market 2021, Click Here @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=Pallavi

The main purpose of this report is to provide up-to-date information relating to the Stem Cell Therapy market and discover all the opportunities for enlargement in the market. The report offers an in-depth study on industry size, shares, demand & supply analysis, sales volume and value analysis of various firms along with segmentation analysis related to significant geographies. This information helps business planners to perform, analyze, or study the market at a minute level. The report not only explores the historic phase of the market, but also analyzes present Stem Cell Therapy market status to provide reliable and precise forecast estimation for trends, consumption, sales, and profitability.

Competitive Analysis

The competitive analysis chapter of the report sheds light on the major developments of the prominent players operating in the Stem Cell Therapy market. The report provides information related to the recent mergers, acquisitions, partnerships, and other strategic alliances within the Stem Cell Therapy market. Further, the pricing, sales, promotional, and marketing strategies of each company are enclosed in the report.

Read complete report with TOC at: https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=Pallavi

Key Market Features in Covid-19 Outbreak:

The report highlights market features, including revenue, weighted average regional price, capacity utilization rate, production rate, gross margins, consumption, import & export, supply & demand, cost bench-marking, market share, CAGR, and gross margin.

Market Highlights & Approach

The report provides the rigorously studied and evaluated data of the top industry players and their scope in the market by means of several analytical tools. The analytical tools such as feasibility study, SWOT analysis, and ROI analysis have been practiced reviewing the growth of the key players operating in the market.

Stem Cell Therapy Market Segmentation

Based on Type, the market has been segmented into:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCsBone Marrow-Derived Mesenchymal SCsEmbryonic SCsOther Sources

Based on application, the market has been segmented into:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal DisordersWounds & InjuriesCardiovascular DiseasesGastrointestinal DiseasesImmune System DiseasesOther Applications

The research provides answers to the following key questions:

1.What is the expected growth rate of the Stem Cell Therapy market?2.What will be the market size for the forecast period, 2021 2026?3.What are the major driving forces responsible for transforming the trajectory of the industry?4.Who are major vendors dominating the Stem Cell Therapy industry across different regions?5.What are their winning strategies to stay ahead in the competition?6.What are the market trends business owners can rely upon in the coming years?7.What are the threats and challenges expected to restrict the progress of the industry across different countries?8.What are the key opportunities that business owners can bank on for the forecast period, 2021 2026?

Key Questions Answered in this Report on the Stem Cell Therapy Market

1.How much revenue will the Stem Cell Therapy market generate by the end of the forecast period?2.Which segment of the market is likely to have the maximum market share by 2026?3.What are the impact factors and their effects on the market for Stem Cell Therapys?4.Which regions currently contribute the maximum share to the overall Stem Cell Therapy market?5.What are the indicators expected to drive the Stem Cell Therapy market?6.What are the essential strategies incorporated by key stakeholders in the Stem Cell Therapy market to expand their geographic presence?7.What are the major advancements being witnessed in the Stem Cell Therapy market?8.How do regulatory norms affect the market for Stem Cell Therapy?

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=Pallavi

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 210-667-2421/ +91 9665341414

Here is the original post:
Impacts of COVID 19 on Stem Cell Therapy Market 2021 Size, Demand, Opportunities & Forecast To 2026 - NeighborWebSJ

Global Stem Cell Therapy Research Report offers the most segmented view of sales data, consumption fields, market size, and revenue across different regions and countries. The vital Stem Cell Therapy insights are derived from primary and secondary authoritative sources. The market dynamics, mergers and acquisitions, Stem Cell Therapy investment feasibility is analyzed in detail. The competitive landscape analyzes the top leading players, market share, revenue, Stem Cell Therapy product portfolio, and opportunities. The qualitative and quantitative methods are used to estimate the Stem Cell Therapy forecast scenario in micro and macro markets. The strategic analysis of Stem Cell Therapy marketing channels, positioning, growth strategies, new entrants, and existing player's competition is done. The product or service which shows more customer inclinations, technological advancements, and economic developments are analyzed.

Request A Free Sample Report to understand the market and have an [emailprotected]https://www.reportscheck.com/shop/2021-2026-report-on-global-stem-cell-therapy-market-by-player-region-type-application-and-sales-channel-2/#sample-request

Osiris TherapeuticsNuVasiveChiesi PharmaceuticalsJCRPharmaceuticalPharmicellMedi-postAnterogenMolmedTakeda (TiGenix)

The product-wise categorization is as follows:

AutologousAllogeneic

The application-level analysis is as follows:

Musculoskeletal DisorderWounds & InjuriesCorneaCardiovascular DiseasesOthers

Check complete table of contents and report details [emailprotected]https://www.reportscheck.com/shop/2021-2026-report-on-global-stem-cell-therapy-market-by-player-region-type-application-and-sales-channel-2/#table-of-contents

The top regions analyzed in this report are North America, Europe, Asia-Pacific, Latin America, Middle East & Africa, and the rest. Also, these regions are further broken down based on Stem Cell Therapy presence in United States, Germany, France, UK, Spain, Italy, Poland, Russia, China, India, Japan, South Korea, Thailand, Indonesia, Philippines, Malaysia, Vietnam, Singapore, Brazil, Argentina, Saudi Arabia, UAE, Qatar, Bahrain and rest. The historical analysis is conducted from 2015-2019, with the base year as 2019, estimated year as 2020, and the forecast period is from 2020-2027.

Stem Cell Therapy analysis report covers the future growth scenario by 2026, with market shares and growth opportunities. The growing demand for Stem Cell Therapy in developed and developing countries, product features, and a wide range of applications will foster industry growth.

Explore complete details and insights with structured free sample [emailprotected]https://www.reportscheck.com/shop/2021-2026-report-on-global-stem-cell-therapy-market-by-player-region-type-application-and-sales-channel-2/

The report begins with Stem Cell Therapy Industry overview, introduction, objectives, and market definition. The market segmentation by type, geographies, applications, and top companies is provided. An increase in Stem Cell Therapy demand, trends, development, and SWOT analysis is provided. The five-year forecast assessment will help in analyzing the industry drivers, restraints, key product segments that will lead to informed decision making.

The vendors, suppliers, traders, distributors, raw material suppliers are analyzed in detail by the Reportscheck team. Even the Stem Cell Therapy analysis based on population, route of administration, distribution channel, and demand is done. The recent developments, the impact of domestic and localized Stem Cell Therapy market players, market regulations, product approvals, and launches is stated.

1. What is the investment feasibility for the new Stem Cell Therapy market entrants and what are the growth opportunities?

2. Which is the most profitable segment in terms of revenue accumulation, market size, geographical presence, and market share?

3. Which key trends, regulatory scenarios, and developments are key attractions for the emerging and existing market players?

4. What are the marketing strategies followed by top company players which keep them ahead of the competition?

5. How COVID-19 pandemic is impact different Stem Cell Therapy economies across different geographies?

6. Which are the growth driving Stem Cell Therapy industry elements which will lead to revenue maximization, new product launches, and lucrative profits?

The complete historical, real-time, as well as forecast developments impacting the market, are studied. The comprehensive company profiles will offer a clear picture of dominating market players. The revenue share analysis by key players will lead to an understanding of the growing scope in this field. Also, valuable conclusions, analyst opinions, implied research methodology is provided.

To understand the market scenario or for any queries contact our analyst team to create a revenue impact solution for your business.

Contact Us:

Olivia Martin

Marketing Manager

Email: [emailprotected]

Website:www.reportscheck.com

https://neighborwebsj.com/

Link:
Stem Cell Therapy Market: Clear Understanding of The Competitive Landscape and Key Product Segments 2026 NeighborWebSJ - NeighborWebSJ

IndustryGrowthInsights publishes a detailed report on Animal Stem Cell Therapy market providing a complete information on the current market situation and offering robust insights about the potential size, volume, and dynamics of the market during the forecast period, 2020-2027. This report offers an in-depth analysis that includes the latest information including the current COVID-19 impact on the market and future assessment of the impact on Animal Stem Cell Therapy Market. The report contains XX pages, which will assist clients to make informed decision about their business investment plans and strategies for the market. As per the report by IndustryGrowthInsights, the global Animal Stem Cell Therapy market is projected to reach a value of USDXX by the end of 2027 and grow at a CAGR of XX% during the forecast period.

Get FREE Exclusive PDF Sample Copy of This Report: https://industrygrowthinsights.com/request-sample/?reportId=171131

The Animal Stem Cell Therapy market report also covers an overview of the segments and sub-segmentations including the product types, applications, and regions. In the light of this harsh economic condition as prompted by the COVID-19 outbreak, the report studies the dynamics of the market, changing competition landscape, and the flow of the global supply and consumption.

The report exclusively deals with key areas such as market size, scope, and growth opportunities of the Animal Stem Cell Therapy market by analyzing the market trend and data available for the period from 2020-2027. Keeping 2020 as the base year for the research study, the report explains the key drivers as well as restraining factors, which are likely to have major impact on the development and expansion of the market during the forecast period.

The report, published by IndustryGrowthInsights, is the most reliable information as the study relies on a concrete research methodology focusing on both primary as well as secondary sources. The report is prepared by relying on primary source including interviews of the company executives & representatives and accessing official documents, websites, and press release of the private and public companies.

The report, prepared by IndustryGrowthInsights, is widely known for its accuracy and factual figures as it consists of a concise graphical representations, tables, and figures which displays a clear picture of the developments of the products and its market performance over the last few years. It uses statistical surveying for SWOT analysis, PESTLE analysis, predictive analysis, and real-time analytics.

Customize Report and Inquiry for the Animal Stem Cell Therapy market Report: https://industrygrowthinsights.com/enquiry-before-buying/?reportId=171131

Furthermore, the scope of the growth potential, revenue growth, product range, and pricing factors related to the Animal Stem Cell Therapy market are thoroughly assessed in the report in a view to entail a broader picture of the market. The report also covers the recent agreements including merger & acquisition, partnership or joint venture and latest developments of the manufacturers to sustain in the global competition of the Animal Stem Cell Therapy market.

Competition Landscape:

The report covers global aspect of the market, covering

Global Animal Stem Cell Therapy market by Types:

DogsHorsesOthers

Global Animal Stem Cell Therapy market by Applications:

Veterinary HospitalsResearch Organizations

Key Players for Global Animal Stem Cell Therapy market:

Medivet Biologics LLCVETSTEM BIOPHARMAJ-ARMU.S. Stem Cell, IncVetCell TherapeuticsCelavet Inc.Magellan Stem CellsKintaro Cells PowerAnimal Stem CareAnimal Cell TherapiesCell Therapy SciencesAnimacel

Avail the Discount on this report @ https://industrygrowthinsights.com/ask-for-discount/?reportId=171131

IndustryGrowthInsights offers attractive discounts on customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

Our reports are more than just research reports to us. They are tools that enable us to maintain long-term relationships with our clients whom we honor and cherish. Our clients business growth is integral for not only them but also us. This is what differentiates us from other market research companies.

At IGI, we provide our expertise and guideline for success. Our team of efficient and experienced researchers and consultants provide progressive market intelligence reports that are accurate, authentic, and in-depth. This empowers the clients to make well-informed decisions.

Moreover, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries including chemicals and materials, energy, automobile, healthcare, consumer goods, and technology. Our deep understanding of many business environments across industries such as those mentioned above allows us to deliver tailor-made reports.

Contact Us:Name Alex MathewsPhone No.: +1 909 545 6473Email [emailprotected] Website https://industrygrowthinsights.com/ Address 500 East E Street, Ontario, CA 91764, United States.

https://murphyshockeylaw.net/

Follow this link:
Animal Stem Cell Therapy Market Research Report And Predictive Business Strategy By 2027 | Industry Growth Insights - Murphy's Hockey Law

With increased awareness of diabetes in all its forms, more funding, compassion, and innovation will follow.

Would you rather have $1.6 million or $123 million ? Which would make a bigger impact in your life?

Personally, Id rather have $123 million, and Im betting you would say the same.

Think of the impact that could be made with that amount of money. You could pay off your student loans, mortgage, and car payment. You could afford the best of the best when it comes to healthcare, food, and experiences.

What would be louder? A crowd of 1.6 million people or 123 million?

Of course, 123 million people would be louder.

According to the American Diabetes Association (ADA), approximately 1.6 million people in the United States live with type 1 diabetes, 34 million people live with type 2 diabetes, and more than 88 million people have prediabetes.

In total, that makes 123 million Americans who are affected by this disease in one form or another.

Do you think we can make more of an impact as a community of 1.6 million people or 123 million?

There are so many factors that contribute to our ability to prevent and manage diabetes in the United States, including access to healthcare and lifesaving medications like insulin, access to healthy foods, finding time to exercise, and so much more.

As a community, we also have a branding problem.

The pink ribbon was introduced for breast cancer awareness in 1991. While its initial debut made quite the splash (and there has been a lot of controversy surrounding its use), it took roughly 15 years before the world took notice.

We now see the pink ribbon everywhere come October.

If the diabetes community is following the same trajectory for awareness as the breast cancer community, things are about to get interesting: 2021 marks 15 years since the blue circle was introduced by the International Diabetes Federation.

Kris Maynard, who lives with type 1 diabetes, is a firefighter and EMT who founded Glucose Revival as a solution to an all too common problem: people with diabetes experiencing low blood sugar levels.

Following the recommendations from the ADA, Glucose Revival makes a necklace that contains 15 grams of quick-acting glucose thats easy to carry, find, and use. Its similar to what EMTs administer daily to people experiencing low blood sugar emergencies.

Maynard is a passionate advocate for uniting the diabetes community. Recently, he approached some of the largest type 1 and type 2 diabetes nonprofit organizations with the idea of adding the blue circle around their logos so that people with diabetes and the world can recognize the blue circle as a symbol of diabetes.

These organizations have incredible influence, which is a key factor in helping us get the message to our legislators, and they dont realize that yet, he says. They dont recognize the power of unity, the power of simplicity, and the power of what the blue circle can bring to the world.

While the top diabetes organizations might not be ready for a rebranding, Maynard is making strides in his local community.

Last November, he asked local landmarks in his community, like the Spokane Pavilion and Steam Plant, to light up blue for American Diabetes Month. Much to his delight, they obliged.

With increased awareness of the disease in all its forms, more funding, compassion, and innovation will follow. To get people to care about this disease, we have to share the stories of the people living with it.

Erik Douds is an endurance athlete living with type 1 diabetes, an adventure filmmaker, and the founder of Diabadass, an education platform where people with diabetes can learn from others living with the disease.

The main reason I make films is to show what life is like with an invisible disease, Douds says.

Ive stayed in the homes of over 60 people living with T1D and visited the technology companies and organizations that make this community. Eventually, I discovered it is the people who have become friends that I learn from the most, which is why I started Diabadass.

Douds is no stranger to roadblocks in his efforts to unite the community, and he says the greatest challenge to unity is when the community loses trust in leadership.

When the community sees themselves at the table, in the truest sense, I think we will see greater collaboration and inspiration for us to all unite, Douds says.

As a creator in the space, my greatest challenge is finding investments in storytelling to share the incredible work being done, alongside the stories that need to be felt in the hearts and minds of leaders outside our space, he says.

In addition to encouraging your favorite diabetes organizations to recognize the blue circle and inviting local landmarks to illuminate with blue lights, both Maynard and Douds call for people to recognize our similarities instead of focusing on our differences.

Douds recommends researching the stereotypes of any types of diabetes to become a better ally for others.

While each type is different, focusing on everything that separates us blinds us from finding our closest allies, he says.

Maynard agrees.

I hear a lot of comparisons between type 1 and type 2 diabetes, as if one is worse than the other, he says. But I have never met anyone with diabetes who wants to have diabetes, so at the very least, we have that much in common.

Sydney Williams is an adventure athlete and author based in San Diego, California. Her work explores how trauma manifests in our minds and bodies, and how the outdoors can help us heal. Sydney is the founder of Hiking My Feelings, a nonprofit organization on a mission to improve community health by creating opportunities for people to experience the healing power of nature. Join the Hiking My Feelings Family, and follow along on YouTube and Instagram.

Read the original post:
Beyond the Blue Circle: Why We Need Unity in the Diabetes Community - Healthline

Advocacy groups are calling on public health officials to prioritize vaccinating Type 1 diabetes patients in their COVID-19 vaccine distribution plans, citing new research on the risks of serious complications after contracting the virus.

A group of 19 diabetes advocacy organizations recently sent a letter to top CDC officials requesting the federal agency recommend that individuals with Type 1 diabetes be included in prioritized vaccine populations. The CDC sets guidelines for tiered vaccine distribution at the state level which state governments have largely followed.

The guidelines say that people between the ages of 65 and 74 and those between 16 and 64 with underlying medical conditions should receive the COVID-19 vaccine in Phase 1C of the rollout. The underlying medical conditions listed include kidney disease, heart disease and Type 2 diabetes, but not Type 1.

The new science leaves little doubt that there should be no distinction between individuals with Type 1 and Type 2 diabetes mellitus, given the common, heightened risk both groups face for the most severe health outcomes of COVID-19, the groups wrote to the CDC last week.

The CDC did not immediately respond to a request for comment.

Disagreements over who should be included in prioritized groups for the vaccine have stemmed in large part from a limited supply of doses. The federal government recently introduced a policy of not holding back second doses of the Pfizer and Moderna vaccines, instead using all available doses to vaccinate as many people as possible.

Robert Gabbay, the chief scientific and medical officer of the American Diabetes Association, said the groups concern began when members noticed that new research showed that Type 1 diabetes carried at least the same risks associated with the novel coronavirus as Type 2 diabetes.

Individuals with Type 1 diabetes are at a 3.3 times higher risk of developing severe illness and are 3.9 times more likely to be hospitalized than those without diabetes, similar to those with Type 2 diabetes, according to the letter to the CDC.

Gabbay said early on in the pandemic, data was more clear that Type 2 diabetes could lead to serious complications in COVID-19 patients. That was due in part, he said, because of the significantly higher number of people who have Type 2 than Type 1 and also because Type 1 patients are sometimes misclassified as Type 2 when hospitalized.

Of the 34 million Americanswith diabetes, almost 1.6 million have Type 1, compared with about 32.6 million with Type 2.

Jen Horney, a professor of epidemiology at the University of Delaware, said a reason why Type 1 diabetes may not have been initially considered as an underlying condition is because of the other health effects of Type 2 that have garnered more attention from the medical community.

She said individuals with Type 2 are more likely to also suffer from comorbidities such as obesity and kidney disease, both of which are included as underlying conditions by the CDC.

The classic example in epidemiology is that people who worked around asbestos were at a higher risk of getting cancer, but people who worked around cancer and smoked there was a synergistic effect, she said. Its more than just additive.

George Huntley, chief executive officer of both the Diabetes Patient Advocacy Coalition and the Diabetes Leadership Council, said that in addition to signing the CDC letter, his organization has sent more than 1,200 letters to governors and state health department officials to open a second front in the effort to include Type 1 diabetes in the prioritized group.

We engaged our policy engine, we engaged our collaborative engine and we also engaged the patients to allow their voices to be heard on this issue thats very important, Huntley said.

Only four states Delaware, Ohio, Tennessee and Virginia consider Type 1 diabetes as an underlying medical condition, Huntley said, adding that updating CDC guidelines would increase the odds of more states adding the disease to their list of prioritized vaccine recipients.

We hope that the CDC will help with that and get them where they need to be, said Stewart Perry, vice chair of the Diabetes Leadership Council board. But were going to continue to focus on the states as well as the CDC.

Go here to see the original:
Advocacy groups call for including Type 1 diabetes among prioritized vaccine recipients | TheHill - The Hill

Its a new year, and COVID-19 vaccines offer hope for those wanting to protect themselves, especially people with underlying health conditions such as diabetes.

You may have questions about these new vaccines, including when you can get them and what questions you should ask your doctor about them. Experts we talked with say the vaccines are safe, effective, and important for people with diabetes.

The most important thing is that people with diabetes get vaccinated as soon as it becomes available to them, says Robert Gabbay, MD, PhD, chief science and medical officer for the American Diabetes Association (ADA) in Arlington, Virginia.

Below, we detail what you need to know about the COVID-19 vaccines.

RELATED: 10 Diabetes Care Tips to Follow During the COVID-19 Pandemic

It depends on where you live. At a federal level, the Centers for Disease Control (CDC) makes recommendations about who should receive priority for vaccination. It is then up to each state to use those recommendations to plan for and distribute vaccines to counties and residents.

Even so, guidelines are changing. In mid-January, U.S Health and Human Services (HHS) Secretary Alex Azar said Americans 65 years and older and those who are younger but have underlying health conditions should receive priority, as AARP reports.

If your state is following the CDCs recommendations, healthcare workers and nursing home residents are receiving first priority for the vaccine. Next, the CDC recommends vaccinating frontline workers such as firefighters, teachers, and grocery store workers, along with people over 75.

Then, the CDC recommends vaccinating people with type 2 diabetes and other underlying medical conditions due to their increased risk of severe COVID-19-associated illness.

People with type 1 diabetes do not currently have the same priority vaccination with the CDC. But groups including theJuvenile Diabetes Research Foundation (JDRF) and the ADA are advocating for this priority at a federal and state level.

Justin Gregory, MD, assistant professor of pediatrics at Vanderbilt Childrens Hospital in Nashville, who has type 1 diabetes, says that people with type 1 diabetes should have the same priority for vaccination as people with type 2 diabetes because both groups have a similarly increased risk for dangerous and deadly COVID-19 illness.

In the end, states make their own decisions about vaccination priority, so check your state and local health departments website to find out when you are eligible. The ADA has also assembled links to individual states vaccination plans as part of its COVID-19 Vaccination Guide.

RELATED: Track the Vax: Delivering COVID-19 Vaccines at Warp Speed

Potentially. The CDC notes notes that the risk for hospitalization increases with the more high-risk medical conditions a person has its 2.5 times for a person with one condition and 5 times for people with three or more conditions. Nevertheless, having comorbidities, such as heart and kidney disease, does not mean you will be allowed to get vaccinated before someone with only diabetes or another single health condition. Again, it comes down to where you live.

In Massachusetts, for example, people with two or more underlying conditions are prioritized to get a COVID-19 vaccine before those with only one condition. Other states do not designate priority by the number of underlying medical conditions.

Where you can get a vaccine also varies depending on where you live. You may be able to sign up for notification about availability of the vaccine with your county or healthcare provider. Pharmacies, hospitals, doctors offices, and health departments will likely all play a role in administering the vaccine, according to a November report by the Kaiser Family Foundation. Your doctor can also guide you on where to seek a vaccine in your hometown.

Its quite clear that people with diabetes do much worse than people without diabetes in terms of their outcomes with COVID, says Dr. Gabbay. Early in the pandemic, astudy from the CDC found that roughly half of people who died from COVID-19 under age 65 had diabetes.

The protective effects of vaccines are critical for people with diabetes who are at increased risk for severe and deadly infection from COVID-19,says Dr. Gregory. His December 2020 study in Diabetes Care found that people with type 1 or type 2 diabetes are 3 times more likely to be hospitalized or experience severe COVID-19 illness compared with people without diabetes.

Two studies from the United Kingdom showed similar risk. An October 2020 study in The Lancet Diabetes & Endocrinology found that people with type 1 or type 2 diabetes were 2 to 3 times more likely to die from COVID-19 in the hospital than people without diabetes. And a December 2020 study in The Lancet Diabetes & Endocrinology found that people with type 1 or type 2 were more likely to die or to be treated in the intensive care unit for COVID-19.

Vaccinations for Black, Latino, and Native Americans are critical because these communities are disproportionately affected by both diabetes and COVID-19. African Americans and Latino Americans are over 50 percent more likely to have diabetes than white Americans, according to the ADA. Black, Latino, and Native Americans experienced a death rate from COVID-19 double or more than white Americans in 2020, according to the CDC.

RELATED: Black Americans Have Been Hit Hardest by COVID-19 Heres Why

Two COVID-19 vaccines are currently available in the United States and people with diabetes were included in both the vaccine trials. Both require two doses spaced either 21 days (Pfizer-BioNTech vaccine) or 28 days (Moderna vaccine) apart. With their two doses completed, these vaccines are over 90 percent effective and received emergency use authorization from the U.S. Food and Drug Administration (FDA) in December 2020.

We wanted to make sure we recruited a number of individuals who had the types of underlying medical conditions that can make COVID more severe, says C. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program in Nashville and part of the phase 3 trials of the Moderna COVID-19 vaccine.

That included people with diabetes, hypertension, and obesity, says Dr. Creech. People with type 1, type 2, and gestational diabetes were included in the Moderna clinical trial, he adds. The FDA filing from Pfizer-BioNTech says the trial included people with diabetes but does not specify among types.

The vaccines were well-tolerated, highly efficacious, and elicited an immune response in people with underlying conditions, such as diabetes, says Creech.

People with diabetes are going to be prioritized [for COVID-19 vaccination] because we know theyre at increased risk for disease. And they should feel confident that someone a whole lot like them was enrolled in the clinical trial so that we can say with a greater degree of certainty that they can effectively get this vaccine, says Creech.

Gabbay says that the data do not suggest the COVID-19 vaccines pose particular risk for people with diabetes. He also says there is no reason to think there would be interactions with insulin or other medications that people with diabetes might take.

RELATED: America Wants to Know: Where Are Our COVID-19 Vaccines?

In general, the most common side effects of both vaccines are pain, swelling, and redness at the injection site. Other common side effects are chills, tiredness, and headaches. Most of these side effects were mild, but some people had more severe reactions that interfered with daily activities.

Gabbay says side effects of the COVID-19 vaccines are similar to those of flu vaccines. For someone living with diabetes, keeping a sick-day kit with extra medications and supplies is beneficial in case you do not feel well.

Gabbay says the first question patients should ask their providers about the COVID-19 vaccine is, When can I get it?

Be proactive in calling your provider to ask for the vaccine, says Gabbay. Check the websites of your state and local health departments to find out about local vaccine distribution. Being patient, persistent, and informed is the best approach, says Gabbay.

Read this article:
COVID-19 Vaccines for People With Diabetes: 8 Must-Know Facts - Everyday Health

The question here is which component of an average persons diet triggers insulin resistance? Is it carbohydrates or vegetable oils? Refined sugars and refined oils would take the cake with their high PUFA levels. When combined, these two are the chief reasons behind insulin resistance. These omega-6 fats cause adipocytes or adipose cells, to signal to the peripheral cells to become resistant to insulin.

Apart from this, the PUFAS present in these oils and trans-fats are stored primarily in the fat cells and do not get used fuel. They also stay in your cells for 600-700 days and end up permeating into tissues and organs, including the heart and brain.

PUFAS are largely responsible for clogging up your cells and creating oxidative stress and inflammation. A diet that includes vegetable oils, including deep-fried junk food, processed fats and other processed materials, will lead to diabetes somewhere down the line. Even cold pressed seed oils that most people regard as healthy would create the same problems discussed above. There are a lot of misconceptions surrounding diabetes and carbohydrates.

Continue reading here:
Can eating carbs lead to diabetes? - Times of India

To prevent or manage diabetes, your doctor has probably told you to pay attention to what you eat, exercise often, and understand your familys health history. But the quality of the air you breathe could also play a role in your risk for the disease or how well youre able to stabilize your blood sugar. Emerging studies are shedding light on the relationship between air pollution and diabetes.

Wildfire smoke is one example of air pollution, and it's associated with an increase in the risk of health complications in people with diabetes, according to a study published in June 2020 in Environmental Health Perspectives. In other research, such as a review published in September 2020 in Gut Microbes, scientists have uncovered the surprising role that air pollution in cities can play in altering gut bacteria and increasing diabetes risk.

In diabetes care, we focus on the whole person. What is their environment? How do they live? Where do they live? says Melissa Young, PharmD, BC-ADM, CDCES, a clinical pharmacist and spokesperson for the Association of Diabetes Care and Education Specialists (ADCES). Dr. Young provides telehealth primary care for the Department of Veterans Affairs across several states, including Colorado and Idaho.

RELATED: 8 Surprising Risk Factors for Type 2 Diabetes

The global toll of air pollution on diabetes is significant, according to a study published in July 2018 in the Lancet Planetary Health. An estimated 3.2 million cases of diabetes globally could be attributed to elevated air pollution in 2016, with increasing burden falling on people living in low- and lower- to middle-income countries.

Its only recently that air pollution has been considered as a factor contributing to greater risk for type 2 diabetes, says Tanya Alderete, PhD, an assistant professor at the University of Colorado in Boulder who studies the causes and consequences of type 2 diabetes.

Dr. Alderete uncovered health disparities for Latino children living in urban Los Angeles from 2001 to 2012. She found that increased air pollution increased risk factors for type 2 diabetes such as decreased insulin sensitivity and reduced production of insulin in overweight and obese children. Herfindings were published in July 2017 in Diabetes.

Why is pollution so bad? Pollution carries fine particles, including metals and other toxins, that inflame the lungs and other parts of the body. Some experts hypothesize that inflammation from fine particles in air pollution increases the risk of type 2 diabetes.

Alderete suspects air pollution changes the gut in unhealthy ways, potentially contributing to type 2 diabetes. Young adults in Southern California with greater exposure to air pollution had less-diverse gut microbiomes, according toone of her studies, which was published in May 2020 in Environmental International. The gut microbiome is the group of microorganisms, including bacteria, that help your body break down food and may protect against infection.

Air pollution alone does not cause diabetes, cautions Alderete. Its a constellation of risk factors that include poor diet, poor physical activity, and greater exposure to environmental toxicants, she says.

Nevertheless, people should try to limit exposure to air pollution from traffic and industry as much as possible. Try to exercise away from busy roadways. Its never a bad idea to check air quality levels before going outside to exercise. Air quality is now included in many weather apps, or you can download air-quality specific apps like AirVisual.

She hopes her research helps policy makers improve air quality standards and promote changes in public health policy. That could mean building schools or developing affordable housing further away from busy roadways, says Alderete.

RELATED: Loneliness May Be a Risk Factor for Type 2 Diabetes, Study Finds

People with diabetes need to be aware of their surroundings and the air quality, says Young.

Smoke from wildfires is an increasing source of air pollution, according to a report published in November 2020 in the New England Journal of Medicine. Researchers have found people with diabetes may be negatively affected by smoke.

In the previously mentioned study, researchers examined ambulance dispatch calls of roughly 500,000 people over five fire seasons in British Columbia. These included severe fire seasons in 2010, 2014, and 2015, when more than 740,000 acres burned.

Exposure to elevated levels of fine particulate matter in smoke was associated with increased ambulance dispatches, within 24 to 48 hours, for episodes of high and low blood sugar, says Jiayun Yao, PhD, who led the research while at the University of British Columbia School of Population and Public Health. She now works for the British Columbia Centre for Disease Control in Vancouver.

Just the stress of having a fire nearby could increase blood glucose, says Young, a certified diabetes care and education specialist, adding that continued high blood glucose can produce extremely high levels of ketones leading to diabetic ketoacidosis (DKA), a serious and life-threatening complication that is more common in people with type 1 diabetes than those with type 2.

People with diabetes may be more sensitive to fine particles in smoke, especially in light of their high prevalence of heart disease, says Young. Indeed, air pollution has been shown to double the risk for hospital admissions for heart disease in people with diabetes, according to a study in Epidemiology.

RELATED: How Wildfire Smoke Affects Your Health

People with diabetes need to be aware of the potential impact from poor air quality events such as wildfire smoke, and to have an action plan to reduce exposures, Dr. Yao says.

Young recommends that individuals managing diabetes keep track of changes to blood sugar and call their diabetes care team with any questions. She recommends keeping a list of your providers phone numbers handy for when questions arise.

She says that paper or surgical masks, scarves, and bandanas will not protect your lungs from the fine particles in wildfire smoke. An N95 respirator may help reduce the risk, but it must fit properly, so ask your physician if youre considering purchasing one (N95 masks are also in short supply during the pandemic).

A sick day kit is also essential for emergencies because it has enough medication, food and supplies to get you through several days. You can learn how to make a sick day kit at the ADCES website.

We need to be careful and be prepared, says Young, adding that the COVID-19 pandemic has recently forced patients and providers to prepare for all kinds of disasters including wildfires. The Centers for Disease Control and Prevention (CDC) also has information on dealing with wildfires.

RELATED: How to Prepare for a Hurricane if You Have Diabetes

Reducing exposure to air pollution is important for people with diabetes, says Young. Monitor air quality by visiting AirNow.gov, the U.S. Air Quality Index, to find the latest information in your area, she says. Use apps on your phone or tablet or watch the local news to keep tabs on air quality.

Try to stay inside if its a high-pollution day and its recommended to stay indoors if you have a chronic condition. Dont go outside for your walk, says Young.

Being inside more means paying attention to indoor air quality, too. Make sure the filters on your HVAC system are clean, says Young. You can use an air purifier or portable air cleaner designed for single areas of the home. Air cleaners wont remove all pollutants from the air, but they can help, says Young, who recommends checking out the U.S. Environmental Protection Agencys Guide to Air Cleaners in the Home. If the air quality is bad, dont do anything to stir up the air, like vacuuming.

Always be prepared, watchful, and aware of your surroundings, says Young. Be as healthful as possible. Keep up with blood glucose testing, and if you have questions, check with your diabetes care team.

RELATED: How Exercise Helps Prevent and Manage Type 2 Diabetes

Visit link:
Air Pollution and Type 2 Diabetes: Is There a Connection? - Everyday Health

In an effort to understand patients willingness to adopt remote digital monitoring (RDM) for diabetes, adults with type 1 (T1D) or type 2 diabetes (T2D) living in 30 countries completed a survey weighing its health benefits against the potential inconvenience.

Results, published in JAMA Network Open, indicate patients with diabetes require greater health benefits to adopt more intrusive RDM modalities, food monitoring, and real-time feedback by a health care professional, researchers wrote.

RDM consists of using prescribed sensors to capture patients physiological and behavioral data, which can then be transmitted to their physician to complement in-person consultations or be used to offer real-time feedback provided by artificial intelligence (AI) or a clinician.

The technology is currently used in some clinical settings, but previous research found RDMs costs, like disruptive eating alerts and social stigma, are intrusive to some patients private lives, which may lead to nonadherence. Some patients, however, do prefer RDM for the superior health benefits it can offer compared with the traditional care model.

The researchers designed a vignette-based survey consisting of hypothetical scenarios that described potential applications of RDM. Participants assessed the scenarios based on key components (vignette factors) that are varied to take 1 of several prespecified options (factor levels), the authors explained.

Between February and July 2019, English- and French-speaking participants with T1D or T2D were recruited from multiple channels to complete the survey. Different levels were developed for monitoring tools, duration and feedback loop, and data handling; they were combined to develop 36 unique vignette scenarios.

As part of the survey, each participant assessed 3 randomly selected vignettes by responding to 2 questions, indicating the minimum health benefit they would require to adopt the RDM as their usual care.

A total of 1010 individuals assessed at least 1 vignette, the majority (57%) of whom were female. Nearly 3000 vignette assessments were completed in the study window, with a median of 78 assessments per vignette. Among the participants, 524 had T1D, 723 used insulin, and 687 considered their diabetes controlled.

Data showed:

Despite patients concerns over the intrusiveness of RDM, the researchers noted technological developments could mitigate the effects of these features and reduce the magnitude of health benefits patients expect to adopt RDM.

Our results show that acceptability of RDM is contingent on how it affects health outcomes that are important to patients and how patients perceive its psychological costs, the authors wrote. Therefore, physicians should first discuss the expected efficacy of RDM with patients and codefine treatment goals.

Because the current study only assessed RDM adoption, future studies should examine the association of different RDM modalities, their intrusiveness, and their perceived effectiveness over longer periods of sustained use. Real-world experimental studies are also needed to test actual adoption of RMD, not just perceptions of the technology.

In addition, because many participants were familiar with the use of digital health tools, acceptability rates in the overall population of individuals with diabetes may be lower than study participants, marking a limitation.

Reference

Oikonomidi T, Ravaud P, Cosson E, Montori V, Tran VT. Evaluation of patient willingness to adopt remote digital monitoring for diabetes management. JAMA Netw Open. doi:10.1001/jamanetworkopen.2020.33115

Read the rest here:
Study Weighs Perceived Benefits, Costs of RDM Adoption for Diabetes Management - AJMC.com Managed Markets Network

This article was originally published here

Diabetes Ther. 2021 Jan 20. doi: 10.1007/s13300-020-00996-7. Online ahead of print.

ABSTRACT

The utilization of telemedicine solutions to reduce outpatient clinic visits and visits to physicians offices, thus saving financial and personal resources as well as time, has gained substantial importance in recent years. The COVID19 pandemic has made it necessary to abruptly adjust outpatient care methods in various medical settings that needlessly require consultations in person to monitor and change the disease management of patients in specific risk groups. People with diabetes represent a vulnerable population who need to be protected from avoidable outpatient clinic visits, particularly in times of influenza or other pandemic outbreaks. However, the treatment and care of patients with diabetes and its comorbidities require careful and regular monitoring and therapy adjustments by medical staff. Advanced age or cognitive impairment and insufficient access to the health care system due to low socioeconomic status can complicate the use of possible alternatives to in-person consultations in outpatient clinics or physicians offices. Telemedicine solutions may offer suitable alternatives to standard face-to-face consultations in outpatient settings and provide sufficient access to appropriate diabetes care. Nevertheless, telemedicine methods for monitoring diabetes issues are yet to find widespread use due to numerous barriers, such as a lack of acceptance and doubt about its time- and cost-effectiveness, availability, and potential technical and regulatory issues. This article offers an overview of existing applications that provide telemedicine diabetes care. Furthermore, it discusses potential ways to restructure and revolutionize diabetes outpatient care.

PMID:33474646 | DOI:10.1007/s13300-020-00996-7

Go here to see the original:
Application of Telemedicine in Diabetes Care: The Time is Now - DocWire News

Is Mediterranean diet diabetes-friendly? Here is what you must know about it  |  Photo Credit: iStock Images

New Delhi:A balanced diet has proven to be effective against dealing with various diseases and health conditions. Changes to lifestyle and diet is one of the first things recommended by medical professionals in dealing with a health issue. Diabetes is a chronic disease that plagues the entire world. When looking for a diabetes-friendly diet, it must be kept in mind that different types of diets will affect the symptoms differently. Therefore, it is necessary to pick the right diet. Is the Mediterranean diet a healthy diet option for people suffering from diabetes? Here is what you need to know about it.

The recommended diet for people suffering from diabetes is plant-based as it can help manage blood sugar levels in the body effectively. A diabetes-friendly diet may end up being frustratingly restrictive for some people. This is why the Mediterranean diet can be a healthy diet option as it's easier to follow and diverse. It can not only help control symptoms of type 2 diabetes, but it can also contribute to reducing the risks of developing type 2 diabetes due to its properties of promoting heart health and weight management.

Some common benefits offered by the Mediterranean diet are as follows:

Consuming a balanced diet while avoiding foods that can trigger the symptoms of diabetes may be the first preference, however, following a Mediterranean diet canprove effective against diabetes. Apart from a healthy diet, make sure that you consume a sufficient amount of water and maintain a healthy lifestyle that includes physical activity.

Disclaimer: Tips and suggestions mentioned in the article are for general information purpose only and should not be construed as professional medical advice. Always consult your doctor or a dietician before starting any fitness programme or making any changes to your diet.

Get the Latest health news, healthy diet, weight loss, Yoga, and fitness tips, more updates on Times Now

See original here:
Is the Mediterranean diet diabetes-friendly? Here is what you must know about it - Times Now

This article was originally published here

J Foot Ankle Res. 2021 Jan 19;14(1):8. doi: 10.1186/s13047-021-00447-x.

ABSTRACT

BACKGROUND: Diabetes-related foot disease (DFD) is a leading cause of global hospitalisation, amputation and disability burdens; yet, the epidemiology of the DFD burden is unclear in Australia. We aimed to systematically review the literature reporting the prevalence and incidence of risk factors for DFD (e.g. neuropathy, peripheral artery disease), of DFD (ulcers and infection), and of diabetes-related amputation (total, minor and major amputation) in Australian populations.

METHODS: We systematically searched PubMed and EMBASE databases for peer-reviewed articles published until December 31, 2019. We used search strings combining key terms for prevalence or incidence, DFD or amputation, and Australia. Search results were independently screened for eligibility by two investigators. Publications that reported prevalence or incidence of outcomes of interest in geographically defined Australian populations were eligible for inclusion. Included studies were independently assessed for methodological quality and key data were extracted by two investigators.

RESULTS: Twenty publications met eligibility and were included. There was high heterogeneity for populations investigated and methods used to identify outcomes. We found within diabetes populations, the prevalence of risk factors ranged from 10.0-58.8%, of DFD from 1.2-1.5%, and the incidence of diabetes-related amputation ranged from 5.2-7.2 per 1000 person-years. Additionally, the incidence of DFD-related hospitalisation ranged from 5.2-36.6 per 1000 person-years within diabetes populations. Furthermore, within inpatients with diabetes, we found the prevalence of risk factors ranged from 35.3-43.3%, DFD from 7.0-15.1% and amputation during hospitalisation from 1.4-5.8%.

CONCLUSIONS: Our review suggests a similar risk factor prevalence, low but uncertain DFD prevalence, and high DFD-related hospitalisation and amputation incidence in Australia compared to international populations. These findings may suggest that a low proportion of people with risk factors develop DFD, however, it is also possible that there is an underestimation of DFD prevalence in Australia in the few limited studies, given the high incidence of hospitalisation and amputation because of DFD. Either way, studies of nationally representative populations using valid outcome measures are needed to verify these DFD-related findings and interpretations.

PMID:33468226 | DOI:10.1186/s13047-021-00447-x

Go here to see the original:
Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian...

As personal health technology improves, remote digital monitoring (RDM) has the potential to improve the health of patients with diabetes, but a new study suggests patients have higher expectations of efficacy as the perceived intrusiveness of the monitoring increases.

Theodora Oikonomidi, MSc, of the Center for Research in Epidemiology and Statistics and the University of Paris, and colleagues wanted to better understand how patient adoption of interventions like RDM are tied to their expectations about the benefits of such programs.

Previous studies have identified the costs of RDM, including disruptive alerts and social stigma, which represent the intrusiveness of RDM in patients private lives, they wrote. Intrusiveness can lead to nonadherence to RDM among some patients, but others may decide to adopt RDM despite its intrusiveness to obtain superior health benefits than those offered by the traditional care model.

To gain a better understanding of the impact of effectiveness and intrusiveness on patient adoption and adherence, the investigators designed 36 scenarios describing different combinations of RDM. Variables included different types of monitoring, such as glucose monitoring and food monitoring; different duration and feedback loops, such as feedback from a provider via telehealth or instant feedback using artificial intelligence; and data handling scenarios (private versus public entities handling the data).

A total of 1577 patients with type 1 or 2 diabetes signed up for the study. Sixty-four percent were females, and the median age was 51 years. Participating patients were asked to assess 3 randomly assigned scenarios. A total of 2860 vignette assessments were completed.

In one-third (36%) of assessments, patients said they would use RDM only if it were much more effective at reducing hypoglycemic episodes compared to their current monitoring. However, in the rest of the cases, patients said they would participate in RDM if it were equally effective or just somewhat more effective than their current monitoring program.

Food monitoring, real-time telehealth feedback, and perceived intrusiveness were found to be key factors in patients judgments.

Oikonomidi told HCPLive she was surprised to see so many patients willing to adopt RDM even if it was not more effective than their current monitoring system.

This shows that patients motivations to adopt RDM vary, she said. For example, some patients may adopt RDM to gain reassurance from being able to access their data in real-time.

At the same time, she said, the study makes clear that a significant proportion of patients have misgivings about the technology, and those patients would need alternative supports or modifications that could mitigate some of their concerns.

The study also found significant variability in patient perceptions. In nearly all cases (94%), more than 25% of participants reviewing a particular scenario said they would accept it if it were equally or less effective than their current monitoring, while at the same time, at least 25% of patients reviewing the same scenario said it would be acceptable only if it were more effective than their current monitoring.

The investigators said such variability demonstrates the importance of shared decision-making when physicians assess the cases of individual patients.

Oikonomidi said physicians also need to understand that while patients have become used to various forms of tracking and monitoring in their daily lives, all tracking is not perceived the same way.

The tracking we experience in daily life is often passive and unobtrusive we do not always notice it, she said. RDM is active: it requires that patients complete certain tasks, such as manually log food intake. Also, RDM does not just track us; it usually gives us some feedback on our health status, which is a sensitive topic for many patients.

Instead of merely telling patients to get used to RDM, she said it is important to proactively lower barriers to RDM by seeking ways to make it less intrusive. She and colleagues have a subsequent study proposing ways to do that, which will be published later this month.

The study, Evaluation of Patient Willingness to Adopt Remote Digital Monitoring for Diabetes Management, was published online in JAMA Network Open.

Read more from the original source:
Patients with Diabetes Open to Remote Monitoring, With Caveats - MD Magazine

Ever wonder how much exercise time it takes to start reducing your risk for heart disease and diabetes? It could be as little as 12 minutes, according to a Harvard study published Nov. 17, 2020, in Circulation. Scientists analyzed blood from more than 400 middle-aged men and women before and just after they'd pedaled for 12 minutes on cycling machines, reaching a vigorous rate. In particular, scientists measured levels of almost 600 natural body chemicals (metabolites). Exercise produced significant changes in most metabolites. For example, the level of one metabolite linked to heart disease and diabetes fell by 29%. Another metabolite tied to diabetes risk and liver disease fell by 18%. That suggests, but doesn't prove, that 12 minutes of daily exercise (that includes vigorous activity) might reduce the risk of heart disease and diabetes. What if you're more of a moderate-intensity exerciser? "We don't know yet if moderate-intensity exercise would have a similar effect on metabolites. But study participants started off with very light exercise, and each minute the intensity increased," says Dr. Gregory Lewis, the study's senior author and a cardiologist at Harvard-affiliated Massachusetts General Hospital.

Image: artvea/Getty Images

Disclaimer:As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Read the original post:
12 minutes of exercise might lower risks for heart disease and diabetes - Harvard Health